ArticleDiabetes2026

MODY Is Prevalent in Later-Onset Diabetes and Has Potential for Targeted Therapy but Is Challenging to Identify.

Luke N Sharp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.